HEADER TRANSCRIPTION 08-APR-09 3H0A TITLE CRYSTAL STRUCTURE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA TITLE 2 (PPARG) AND RETINOIC ACID RECEPTOR ALPHA (RXRA) IN COMPLEX WITH 9-CIS TITLE 3 RETINOIC ACID, CO-ACTIVATOR PEPTIDE, AND A PARTIAL AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR RXR-ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 228-455; COMPND 5 SYNONYM: RETINOID X RECEPTOR ALPHA, NUCLEAR RECEPTOR SUBFAMILY 2 COMPND 6 GROUP B MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 10 CHAIN: D; COMPND 11 FRAGMENT: UNP RESIDUES 234-505; COMPND 12 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: NUCLEAR RECEPTOR COACTIVATOR 1, CO-ACTIVATOR PEPTIDE; COMPND 16 CHAIN: B, E; COMPND 17 FRAGMENT: UNP RESIDUES 629-640; COMPND 18 SYNONYM: NCOA-1, STEROID RECEPTOR COACTIVATOR 1, SRC-1, RIP160, COMPND 19 PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 20 EC: 2.3.1.48; COMPND 21 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RXRA, NR2B1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: PPARG, NR1C3; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET30; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 24 ORGANISM_COMMON: HUMAN; SOURCE 25 ORGANISM_TAXID: 9606 KEYWDS PPAR, TRANSCRIPTION, NUCLEAR RECEPTOR FOLD, TRANSCRIPTION REGULATION, KEYWDS 2 HORMONE, GROWTH FACTOR RECEPTOR, COMPLEX, DNA-BINDING, HOST-VIRUS KEYWDS 3 INTERACTION, ISOPEPTIDE BOND, METAL-BINDING, NUCLEUS, RECEPTOR, KEYWDS 4 ZINC-FINGER, ACTIVATOR, DIABETES MELLITUS, DISEASE MUTATION, KEYWDS 5 OBESITY, PHOSPHOPROTEIN, ACYLTRANSFERASE, PROTO-ONCOGENE, KEYWDS 6 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Z.WANG,A.SUDOM,N.P.WALKER REVDAT 4 21-FEB-24 3H0A 1 REMARK REVDAT 3 02-APR-14 3H0A 1 SOURCE VERSN REVDAT 2 23-JUN-09 3H0A 1 JRNL REVDAT 1 09-JUN-09 3H0A 0 JRNL AUTH R.V.CONNORS,Z.WANG,M.HARRISON,A.ZHANG,M.WANSKA,S.HISCOCK, JRNL AUTH 2 B.FOX,M.DORE,M.LABELLE,A.SUDOM,S.JOHNSTONE,J.LIU,N.P.WALKER, JRNL AUTH 3 A.CHAI,K.SIEGLER,Y.LI,P.COWARD JRNL TITL IDENTIFICATION OF A PPARDELTA AGONIST WITH PARTIAL AGONISTIC JRNL TITL 2 ACTIVITY ON PPARGAMMA. JRNL REF BIOORG.MED.CHEM.LETT. V. 19 3550 2009 JRNL REFN ISSN 0960-894X JRNL PMID 19464171 JRNL DOI 10.1016/J.BMCL.2009.04.151 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 33304 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.251 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.342 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1758 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2367 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.19 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 127 REMARK 3 BIN FREE R VALUE : 0.3570 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3965 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 105 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.75000 REMARK 3 B22 (A**2) : 1.39000 REMARK 3 B33 (A**2) : 1.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.09000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.264 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.260 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.216 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.951 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.831 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4115 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5557 ; 1.929 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 492 ; 7.106 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;38.876 ;24.659 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 773 ;22.143 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;15.925 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 642 ; 0.120 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2987 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2484 ; 1.014 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4018 ; 1.740 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1631 ; 2.577 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1539 ; 3.844 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3H0A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-APR-09. REMARK 100 THE DEPOSITION ID IS D_1000052529. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI (111) REMARK 200 OPTICS : 3X3 CCD ARRAY REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35062 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 85.436 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 7.8040 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : 0.35500 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 2000 MONOMETHYL ETHER, 0.3 M REMARK 280 SODIUM ACETATE, 0.1 M HEPES 7.5, VAPOR DIFFUSION, TEMPERATURE REMARK 280 289K, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 89.62900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.91250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 89.62900 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.91250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 244 REMARK 465 LYS A 245 REMARK 465 THR A 246 REMARK 465 GLU A 247 REMARK 465 THR A 248 REMARK 465 TYR A 249 REMARK 465 VAL A 250 REMARK 465 GLU A 251 REMARK 465 ALA A 252 REMARK 465 ASN A 253 REMARK 465 MET A 254 REMARK 465 GLY A 255 REMARK 465 LEU A 256 REMARK 465 ASN A 257 REMARK 465 PRO A 258 REMARK 465 SER A 259 REMARK 465 SER A 260 REMARK 465 PRO A 261 REMARK 465 PHE D 264 REMARK 465 LYS D 265 REMARK 465 HIS D 266 REMARK 465 ILE D 267 REMARK 465 THR D 268 REMARK 465 PRO D 269 REMARK 465 LEU D 270 REMARK 465 THR B 640 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O MET A 452 N MET A 454 1.86 REMARK 500 O ILE D 303 O HOH D 92 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 293 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 230 114.40 -172.60 REMARK 500 VAL A 232 -8.89 -49.92 REMARK 500 LEU A 240 43.62 -78.83 REMARK 500 ALA A 241 -46.39 -145.62 REMARK 500 VAL A 242 43.29 -101.42 REMARK 500 ARG A 285 71.20 -105.36 REMARK 500 PRO A 287 144.21 -38.71 REMARK 500 HIS A 288 2.95 55.42 REMARK 500 SER A 290 47.02 -74.65 REMARK 500 LEU A 292 -132.01 51.29 REMARK 500 LEU A 294 -69.53 -134.91 REMARK 500 LEU A 326 -168.46 -77.42 REMARK 500 VAL A 332 85.87 -69.65 REMARK 500 LEU A 350 -71.81 -55.77 REMARK 500 LEU A 353 -75.10 -109.36 REMARK 500 LEU A 370 -70.37 -53.11 REMARK 500 ARG A 371 -0.15 -54.21 REMARK 500 ALA A 387 36.99 -67.04 REMARK 500 GLU A 388 -67.63 -95.19 REMARK 500 VAL A 389 1.47 -66.43 REMARK 500 GLU A 390 -73.21 -104.00 REMARK 500 LYS A 440 -87.81 -103.01 REMARK 500 LEU A 441 49.40 -85.68 REMARK 500 ILE A 442 -41.06 -140.92 REMARK 500 ASP A 444 -15.44 95.14 REMARK 500 PRO A 446 90.27 -50.53 REMARK 500 GLU A 453 25.54 -36.58 REMARK 500 MET A 454 135.55 130.39 REMARK 500 LYS D 240 46.42 -101.87 REMARK 500 GLU D 276 -177.43 -62.46 REMARK 500 LEU D 393 54.42 -93.09 REMARK 500 MET D 439 4.98 -66.31 REMARK 500 ARG D 443 -17.37 -47.38 REMARK 500 GLN D 444 -70.31 -96.19 REMARK 500 ILE D 445 -38.15 -30.11 REMARK 500 THR D 461 -152.31 55.02 REMARK 500 MET D 463 139.00 -36.56 REMARK 500 LYS D 474 119.52 -37.02 REMARK 500 ASP D 475 9.90 55.80 REMARK 500 HIS B 631 -123.73 47.13 REMARK 500 LEU B 633 74.73 -112.44 REMARK 500 VAL B 634 -16.46 -145.82 REMARK 500 LEU B 637 -91.62 -102.71 REMARK 500 SER E 630 37.54 29.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9RA A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE D30 D 500 DBREF 3H0A A 228 455 UNP P19793 RXRA_HUMAN 228 455 DBREF 3H0A D 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 3H0A B 629 640 UNP Q15788 NCOA1_HUMAN 629 640 DBREF 3H0A E 629 640 UNP Q15788 NCOA1_HUMAN 629 640 SEQRES 1 A 228 GLU ASP MET PRO VAL GLU ARG ILE LEU GLU ALA GLU LEU SEQRES 2 A 228 ALA VAL GLU PRO LYS THR GLU THR TYR VAL GLU ALA ASN SEQRES 3 A 228 MET GLY LEU ASN PRO SER SER PRO ASN ASP PRO VAL THR SEQRES 4 A 228 ASN ILE CYS GLN ALA ALA ASP LYS GLN LEU PHE THR LEU SEQRES 5 A 228 VAL GLU TRP ALA LYS ARG ILE PRO HIS PHE SER GLU LEU SEQRES 6 A 228 PRO LEU ASP ASP GLN VAL ILE LEU LEU ARG ALA GLY TRP SEQRES 7 A 228 ASN GLU LEU LEU ILE ALA SER PHE SER HIS ARG SER ILE SEQRES 8 A 228 ALA VAL LYS ASP GLY ILE LEU LEU ALA THR GLY LEU HIS SEQRES 9 A 228 VAL HIS ARG ASN SER ALA HIS SER ALA GLY VAL GLY ALA SEQRES 10 A 228 ILE PHE ASP ARG VAL LEU THR GLU LEU VAL SER LYS MET SEQRES 11 A 228 ARG ASP MET GLN MET ASP LYS THR GLU LEU GLY CYS LEU SEQRES 12 A 228 ARG ALA ILE VAL LEU PHE ASN PRO ASP SER LYS GLY LEU SEQRES 13 A 228 SER ASN PRO ALA GLU VAL GLU ALA LEU ARG GLU LYS VAL SEQRES 14 A 228 TYR ALA SER LEU GLU ALA TYR CYS LYS HIS LYS TYR PRO SEQRES 15 A 228 GLU GLN PRO GLY ARG PHE ALA LYS LEU LEU LEU ARG LEU SEQRES 16 A 228 PRO ALA LEU ARG SER ILE GLY LEU LYS CYS LEU GLU HIS SEQRES 17 A 228 LEU PHE PHE PHE LYS LEU ILE GLY ASP THR PRO ILE ASP SEQRES 18 A 228 THR PHE LEU MET GLU MET LEU SEQRES 1 D 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 D 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 D 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 D 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 D 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 D 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 D 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 D 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 D 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 D 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 D 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 D 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 D 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 D 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 D 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 D 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 D 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 D 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 D 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 D 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 D 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 12 THR SER HIS LYS LEU VAL GLN LEU LEU THR THR THR SEQRES 1 E 12 THR SER HIS LYS LEU VAL GLN LEU LEU THR THR THR HET 9RA A 500 26 HET D30 D 500 40 HETNAM 9RA 4-[1-(3,5,5,8,8-PENTAMETHYL-5,6,7,8- HETNAM 2 9RA TETRAHYDRONAPHTHALEN-2-YL)ETHENYL]BENZOIC ACID HETNAM D30 [(4-{[2-(PENT-2-YN-1-YLOXY)-4-{[4-(TRIFLUOROMETHYL) HETNAM 2 D30 PHENOXY]METHYL}PHENYL]SULFANYL}-5,6,7,8- HETNAM 3 D30 TETRAHYDRONAPHTHALEN-1-YL)OXY]ACETIC ACID FORMUL 5 9RA C24 H28 O2 FORMUL 6 D30 C31 H29 F3 O5 S FORMUL 7 HOH *105(H2 O) HELIX 1 1 GLU A 233 LEU A 240 1 8 HELIX 2 2 ASP A 263 PHE A 277 1 15 HELIX 3 3 PHE A 277 ALA A 283 1 7 HELIX 4 4 LEU A 294 GLY A 304 1 11 HELIX 5 5 GLY A 304 ARG A 316 1 13 HELIX 6 6 HIS A 333 ALA A 340 1 8 HELIX 7 7 GLY A 343 LEU A 353 1 11 HELIX 8 8 LEU A 353 GLN A 361 1 9 HELIX 9 9 ASP A 363 VAL A 374 1 12 HELIX 10 10 ASN A 385 VAL A 389 5 5 HELIX 11 11 GLU A 390 TYR A 408 1 19 HELIX 12 12 GLY A 413 PHE A 439 1 27 HELIX 13 13 PRO D 206 PHE D 226 1 21 HELIX 14 14 THR D 229 THR D 238 1 10 HELIX 15 15 ASP D 251 ASP D 260 1 10 HELIX 16 16 GLU D 276 SER D 302 1 27 HELIX 17 17 GLY D 305 LEU D 309 5 5 HELIX 18 18 ASP D 310 SER D 332 1 23 HELIX 19 19 ARG D 350 SER D 355 1 6 HELIX 20 20 PRO D 359 PHE D 363 5 5 HELIX 21 21 MET D 364 ASN D 375 1 12 HELIX 22 22 ALA D 376 GLU D 378 5 3 HELIX 23 23 ASP D 380 LEU D 393 1 14 HELIX 24 24 ASN D 402 HIS D 425 1 24 HELIX 25 25 GLN D 430 GLU D 460 1 31 HELIX 26 26 HIS D 466 LYS D 474 1 9 HELIX 27 27 SER E 630 THR E 639 1 10 SHEET 1 A 3 PHE D 247 ILE D 249 0 SHEET 2 A 3 GLY D 346 THR D 349 1 O THR D 349 N ILE D 249 SHEET 3 A 3 GLY D 338 ILE D 341 -1 N VAL D 339 O MET D 348 CISPEP 1 LYS D 358 PRO D 359 0 -3.79 SITE 1 AC1 14 HOH A 117 ILE A 268 ALA A 271 ALA A 272 SITE 2 AC1 14 GLN A 275 LEU A 309 PHE A 313 ARG A 316 SITE 3 AC1 14 LEU A 326 ALA A 327 ILE A 345 CYS A 432 SITE 4 AC1 14 HIS A 435 LEU A 436 SITE 1 AC2 17 HOH D 59 HOH D 60 HOH D 93 HOH D 95 SITE 2 AC2 17 LEU D 255 GLU D 259 ARG D 280 ILE D 281 SITE 3 AC2 17 GLY D 284 CYS D 285 ARG D 288 ILE D 326 SITE 4 AC2 17 LEU D 330 LEU D 340 GLU D 343 LEU D 353 SITE 5 AC2 17 MET D 364 CRYST1 179.258 53.825 67.108 90.00 107.74 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005579 0.000000 0.001785 0.00000 SCALE2 0.000000 0.018579 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015645 0.00000